Martin J Lizak Selected Research

Martin J Lizak Research Topics

Disease

10	Neoplasms (Cancer) 04/2024 - 08/2006
4	Inflammation (Inflammations) 02/2023 - 08/2002
3	Carcinogenesis 02/2023 - 08/2011
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2015 - 03/2012
2	Glioma (Gliomas) 04/2024 - 02/2011
1	Lymphoma (Lymphomas) 04/2024
1	Infarction (Infarctions) 02/2023
1	Cardiomegaly (Heart Hypertrophy) 02/2023
1	Seizures (Absence Seizure) 02/2023
1	Ataxia (Dyssynergia) 02/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2023
1	Meningoencephalitis 01/2019
1	Adenocarcinoma of Lung 08/2016
1	Medulloblastoma 03/2016
1	Colonic Neoplasms (Colon Cancer) 11/2015
1	Disease Progression 01/2014
1	Neoplasm Metastasis (Metastasis) 03/2012
1	Pheochromocytoma 03/2012
1	Hypoxia (Hypoxemia) 03/2012
1	Candidiasis (Moniliasis) 01/2012
1	Choroidal Effusions 11/2008
1	Lymphoid Leukemia 02/2003
1	Leukemia 02/2003
1	Myeloid Leukemia (Leukemia, Myelocytic) 02/2003
1	Arthritis (Polyarthritis) 08/2002
1	Hyperplasia 08/2002

Drug/Important Bio-Agent (IBA)

4	Pyruvic Acid (Pyruvate)IBA 11/2015 - 02/2011
3	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 02/2023 - 08/2011
3	Proteins (Proteins, Gene)FDA Link 02/2023 - 08/2011
3	Lactic Acid (Lactate)FDA LinkGeneric 11/2015 - 02/2011
3	Oxygen (Dioxygen)IBA 09/2014 - 08/2006
2	HydrolasesIBA 02/2023 - 02/2023
2	Dobutamine FDA LinkGeneric 02/2023 - 02/2023
2	Tyrosine Kinase InhibitorsIBA 08/2016 - 09/2014
2	Biomarkers (Surrogate Marker)IBA 09/2014 - 01/2014
2	EnzymesIBA 01/2012 - 08/2011
1	liposomal doxorubicin (Doxil)FDA Link 04/2024
1	Agammaglobulinaemia Tyrosine KinaseIBA 04/2024
1	ibrutinibIBA 04/2024
1	rucaparibIBA 02/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2023
1	Protein Kinases (Protein Kinase)IBA 02/2023
1	CytokinesIBA 02/2023
1	ADP Ribose Transferases (ADP Ribosyltransferase)IBA 02/2023
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2016
1	Cetuximab (Erbitux)FDA Link 08/2016
1	Phosphotransferases (Kinase)IBA 08/2016
1	ErbB Receptors (EGF Receptor)IBA 08/2016
1	AfatinibIBA 08/2016
1	LB100IBA 03/2016
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 03/2016
1	Cisplatin (Platino)FDA LinkGeneric 03/2016
1	Contrast MediaIBA 01/2016
1	ferric oxide (iron oxide)IBA 01/2016
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2015
1	Sunitinib (Sutent)FDA Link 09/2014
1	Angiogenesis InhibitorsIBA 09/2014
1	nitroxylIBA 09/2014
1	LuciferasesIBA 03/2012
1	pimonidazoleIBA 03/2012
1	Antineoplastic Agents (Antineoplastics)IBA 03/2012
1	ADP-ribosylarginine hydrolaseIBA 08/2011
1	polyolIBA 02/2003
1	Aldehyde Reductase (Aldose Reductase)IBA 02/2003
1	Oxidoreductases (Dehydrogenase)IBA 02/2003
1	NADP (NADPH)IBA 02/2003
1	Bacterial DNAIBA 08/2002
1	DNA (Deoxyribonucleic Acid)IBA 08/2002
1	OligodeoxyribonucleotidesIBA 08/2002

Therapy/Procedure

4	Therapeutics 04/2024 - 03/2012
3	Radiotherapy 11/2015 - 02/2011
1	Intravenous Administration 03/2012
1	Intravenous Injections 02/2011
1	Intraocular Injections 11/2008
1	Intravitreal Injections 11/2008